Dominic Borie
Fortuna: 994 140 $ al 30/06/2026
Fortuna: 994 140 $ al 30/06/2026
Dominic Borie is Chief Medical Officer, Head-Research & Development at Cue Biopharma, Inc. since 2026.
Former roles include President-Research & Development at Kyverna Therapeutics, Inc. from 2022 to 2025, VP, Head-External Research & Development at Horizon Therapeutics Ltd. (Ireland), Director-Transplantation Immunology Laboratory at Stanford University, Senior Medical Director at Genentech, Inc., Medical Director at Amgen, Inc., and Executive Director at Allogene Therapeutics, Inc. Education includes a doctorate from The University of Texas at Austin and an undergraduate degree from North Carolina State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,75 % | 13/07/2026 | 31.500 ( 0,75 % ) | 994 140 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CUE BIOPHARMA, INC. | Director Técnico/Científico/I+D | 13/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Director Ejecutivo | 13/10/2022 |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| AMGEN INC. | Director Técnico/Científico/I+D | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.